Back to Search Start Over

Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites

Authors :
Esteban Ballestar
Javier Rodríguez-Ubreva
Laura Ciudad
Almudena R. Ramiro
Francesc Català-Moll
Alejandro Vaquero
Ganesh Poorani-Subramani
Henar Hernando
Antonio Garcia-Gomez
Arantxa Pérez-García
Virginia C. Rodríguez-Cortez
Javier M. Di Noia
Jose Urquiza
Paloma Martinez-Redondo
Instituto de Salud Carlos III
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
Canada Research Chairs
Canadian Institutes of Health Research
Source :
Scientific Reports, Dipòsit Digital de la UB, Universidad de Barcelona, Recercat. Dipósit de la Recerca de Catalunya, instname, Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017), Repisalud, Instituto de Salud Carlos III (ISCIII)
Publication Year :
2016

Abstract

Activation-induced cytidine deaminase (AID) triggers antibody diversification in B cells by catalysing deamination and subsequently mutating immunoglobulin (Ig) genes. Association of AID with RNA Pol II and occurrence of epigenetic changes during Ig gene diversification suggest participation of AID in epigenetic regulation. AID is mutated in hyper-IgM type 2 (HIGM2) syndrome. Here, we investigated the potential role of AID in the acquisition of epigenetic changes. We discovered that AID binding to the IgH locus promotes an increase in H4K20me3. In 293F cells, we demonstrate interaction between co-transfected AID and the three SUV4-20 histone H4K20 methyltransferases, and that SUV4-20H1.2, bound to the IgH switch (S) mu site, is replaced by SUV4-20H2 upon AID binding. Analysis of HIGM2 mutants shows that the AID truncated form W68X is impaired to interact with SUV4-20H1.2 and SUV4-20H2 and is unable to bind and target H4K20me3 to the Smu site. We finally show in mouse primary B cells undergoing class-switch recombination (CSR) that AID deficiency associates with decreased H4K20me3 levels at the Smu site. Our results provide a novel link between SUV4-20 enzymes and CSR and offer a new aspect of the interplay between AID and histone modifications in setting the epigenetic status of CSR sites. This work was supported by grant SAF2014-55942-R from the Instituto de Salud Carlos III, organisms ascribed to the Ministerio de Economia y Competitividad and cofunded by FEDER funds/European Regional Development Fund (ERDF) - a way to build Europe, and the EU FP7 306000 STATegra project. JMDN is supported by a Canada Research Chair tier II. Work by JMDN and SPG was supported by the Canadian Institutes of Health Research, MOP 125991. Sí

Details

ISSN :
20452322 and 20145594
Volume :
7
Issue :
1
Database :
OpenAIRE
Journal :
Scientific reports
Accession number :
edsair.doi.dedup.....342b73dc10911a0dd55979de84c48267